The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
!o..o..o..o..O..O..O..OLLEH
Shhh welcome to the FUM library... nothing to see here (apparently)
SOLID sadly no obvious rerate driver
(re Wardell Armstrong JORC) "almost complete and will be announced separately."
However one frames it, long term holders and recent converts will surely reap rewards in 2022. In Q1 I believe / hope.
GLA
O4L
I dont see the value here limited to a pure covid play, covid is driving changed behaviour with massively greater awareness of benefits of health monitoring and personal responsibility. GBDY fits this zeigeist perfectly.
The investor question is when will this be reflected in the share price?
My view is that if they deliver annualized doubling of revenue and profit over the next 3 years they will be a strong TO candidate and the share price will rerate into the 25 to 40p range.
As ever dyor
O4L
Ah, wishy washy, the son of widow t****ey in Aladdin. How apt to reference a pantomime.
Fair do's though, EUA is being held in a range, I've been a serial buyer and believe that the genie will be released in the next month or so... bring me that lamp, it needs a rub methinks.
If 7 value adding RNS's in the last 2 months are examples of BOD cloak and dagger behaviour I'm looking forward to Dmitry Machiavelli and Christian Stalin being adopted as Non Execs... shortly.
You've gotta laugh
GLALTHs
LSE RNS feed not reliable.
Wake up to VOx rns alerts then tune in to LSE for chat
This is bangos year. Building cash off strong revenues with sticky customers. Ripe for takeover as tech is proven and price in 2022 cheap, compared to potential market cap in 23 and beyond.
RNS trading update (via VOX), ready for rerate and TO target: generating lots of CASH; exponential REVENUE; emerging payments STANDARD.
Who will buy my sweet red roses?
Who will buy two blooms for a penny?
Gla
O4L
Clean coal, gold, green hydrogen at fractions of a penny! ORCP and EUA both massive hydrogen plays, EUA at 25p with massive upside, ORCP languishing at .4 or so.
I'm very happy to hold chunky holdings in both, very impressed with both BODs and looking forward to regular news flow and major rerate
GLA
O4L
A firm start in the 40's with a steady rise in 2022.
Gla investors and long term holders
Live long and prosper
O4L
Slow, slow, quick, quick, slow.
The pharmaceutical dance goes on, all seems so quaint for a simple to apply product that promises to be a global game changer needed for so many.
Happy to hold for gold. Good luck all (patient) shareholders.
Lots of noise on short term SP movement and preoccupation with definitions of shortly.
It is, of course, easier for longer term investors to sit on already stellar gains and await the main prize which I interpret from a succession of RNS's is getting bigger and bigger.
All to their own in terms of research and risk appetite. In the meantime, be great to move the conversation from daily fluctuations and second guessing what the BOD mean by shortly.
GLALTH
When you say "that's a fact" can you elaborate. I'm sure you're right just be good to know what's occurring. I'm invested a reasonable amount but most of my attention on EUA and SYME. (Not ramping either of those btw)
EUA is good news for both traders and investors; traders get to ride short term volatility; meanwhile, investors hold for gold, incense and myrrh believing that the BOD has substantively built value during the sale process.
Grandfather frost (Russian Santa Clause) is loading his slay with presents for all shareholders. I for one will be hanging my EUA stocking (pillow case!) on the end of my bed. You can believe in Christmas or not, but the 25th December (#BIG RNS) will happen.
All the best
O4L - other religious festivals are available xx